| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2019/02/14 | 20:43 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/04/17 | 05:08 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/16 | 21:02 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/10 | 00:52 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/08 | 08:26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/08 | 08:25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/08 | 08:25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/08 | 08:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/08 | 08:23 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/08 | 08:22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/08 | 08:21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/08 | 08:19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/08 | 08:18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/08 | 08:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/08 | 08:16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/08 | 08:15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/08 | 08:14 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/08 | 08:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/06 | 22:33 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/06 | 22:30 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/06 | 22:28 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/06 | 22:26 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/06 | 22:24 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/06 | 22:13 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/06 | 22:02 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/05 | 22:19 | Edgar (US Regulatory) | Amended Statement of Ownership: Private Transaction (sc 13e3/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/05 | 22:13 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/05 | 22:03 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/05 | 22:02 | Edgar (US Regulatory) | Amended Statement of Ownership: Private Transaction (sc 13e3/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |
| 2018/03/05 | 22:02 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:JUNO | Juno Therapeutics, Inc. (delisted) |